The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

CRNX FINANCIAL STATEMENTS

Crinetics Pharmaceuticals Inc — balance sheet, income statement and cash flow trends

CRNXCrinetics Pharmaceuticals Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-400 M-200 M0202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue42.2 M $Gross Profit41.8 M $ · 99%Operating Income-549.1 M $ · -1303%Pre-tax Income-501.4 M $ · -1189%Net Income to Owners-501.6 M $ · -1190%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue42.2 M $+2,928.4%
Gross Profit41.8 M $—
Operating Income-549.1 M $—
EBITDA-509.9 M $—
Net Income to Owners-501.6 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0500 M1 B1.5 B202120222023202420252026

Capital Structure

Q2 2026
Total Assets1.3 B
  • Equity1.2 B $90%
  • Current Liabilities79.9 M $6%
  • Long-term Liabilities50 M $4%

Key Figures

YoY change
Total Assets1.3 B $+2.5%
Total Liabilities129.9 M $+10.1%
Total Equity1.2 B $+1.7%
Cash & ST Investments1.2 B $+0.8%
Total Debt47.2 M $-5.5%
Net Debt-8.3 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-400 M-200 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-400 M-200 M0-422.5 M $Operating-4.2 M $Investing427.9 M $Financing1.3 M $Net Change

Key Figures

YoY change
Operating Cash Flow-422.5 M $—
Capital Expenditures2.7 M $-55.6%
Free Cash Flow-425.2 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on CRNX

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 2, 26. This content is for informational purposes only and is not investment advice.